TELA Bio Price to Book Ratio 2018-2021 | TELA

Historical price to book ratio values for TELA Bio (TELA) over the last 10 years. The current price to book ratio for TELA Bio as of October 22, 2021 is 5.20.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

TELA Bio Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 12.60 5.22
2021-06-30 16.11 $2.42 6.67
2021-03-31 14.90 $2.89 5.16
2020-12-31 15.04 $3.40 4.43
2020-09-30 16.54 $3.90 4.24
2020-06-30 12.96 $4.40 2.95
2020-03-31 7.82 $2.12 3.68
2019-12-31 12.95 $2.71 4.77
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.182B $0.018B
TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company offers a portfolio of advanced reinforced tissue matrices. TELA Bio Inc. is headquartered in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76